Novavax
NVAX
#5858
Rank
C$1.72 B
Marketcap
C$10.52
Share price
-4.66%
Change (1 day)
-1.65%
Change (1 year)

Earnings for Novavax (NVAX)

Earnings in 2026 (TTM): -C$93.88 Million

According to Novavax's latest financial reports the company's current earnings are C$0.59 Billion. In 2025 the company made an earning of C$0.65 Billion, an increase over its 2024 earnings that were of -C$0.23 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Novavax from 1996 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -C$93.88 Million-114.33%
2025 C$0.65 B-396.87%
2024 -C$0.23 Billion-70.39%
2023 -C$0.75 Billion-16.59%
2022 -C$0.9 Billion-62.58%
2021 -C$2.39 Billion320.54%
2020 -C$0.57 Billion234.22%
2019 -C$0.17 Billion-30.17%
2018 -C$0.25 Billion1.69%
2017 -C$0.24 Billion-36.44%
2016 -C$0.38 Billion70.4%
2015 -C$0.23 Billion89.27%
2014 -C$0.12 Billion59.83%
2013 -C$73.03 Million81.9%
2012 -C$40.15 Million50.33%
2011 -C$26.71 Million
2009 -C$52.71 Million8.8%
2008 -C$48.45 Million18.01%
2007 -C$41.05 Million18.33%
2006 -C$34.7 Million168.31%
2005 -C$12.93 Million-62.51%
2004 -C$34.49 Million52.4%
2003 -C$22.64 Million-28.21%
2002 -C$31.53 Million
2000 -C$17.97 Million177%
1999 -C$6.49 Million-11.54%
1998 -C$7.34 Million10.64%
1997 -C$6.63 Million-9.62%
1996 -C$7.34 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Novartis
NVS
C$22.25 B-24,586.50%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
C$14.93 B-16,530.34%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
C$20.67 B-22,848.99%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
C$14.11 B-15,631.18%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sarepta Therapeutics
SRPT
C$34.49 M-137.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-C$0.44 Billion 379.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
C$0.16 B-285.60%๐Ÿ‡บ๐Ÿ‡ธ USA
NanoViricides
NNVC
-C$11.41 Million-87.45%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
-C$0.65 Billion 604.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
C$83.32 M-191.68%๐Ÿ‡บ๐Ÿ‡ธ USA